LaunchPort Resident Nanochon Announces Health Canada Approval for First in Human Investigation
Jul 10, 2025
- 1 Comment
Nanochon (https://www.nanochon.com/), a Baltimore-based orthopedic device biotech company developing an implant for treating articular cartilage defects in the knee, is thrilled to announce that it was granted Health Canada Approval for their first in human clinical trial. Nanochon is the first company to join LaunchPort’s Advanced Manufacturing Facility, which received recent support from Maryland’s Build […]
Read More